|Bid||43.04 x 2000|
|Ask||44.09 x 1900|
|Day's Range||43.06 - 43.91|
|52 Week Range||36.58 - 47.82|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
Bristol-Myers Squibb (BMY) is expected to report a rise of ~4.4% in its earnings to $5.1 billion for 2Q17 on July 27, 2017.
Eli Lilly (LLY) surpassed Wall Street analysts’ revenue estimates of $5.21 billion with reported revenues of $5.23 billion during 1Q17.
Allergan's revenues are driven by the strong performance of products under its key brands as well as the inclusion of revenues from LifeCell and other acquisitions.